期刊名称：JOURNAL OF COSMETIC DERMATOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Journal of Cosmetic Dermatology
© 2014 Wiley Periodicals, Inc.
Instructions to Authors
Author Guidelines
Journal of Cosmetic Dermatology
Instructions for Authors
Manuscripts must be submitted online. For complete detailed instructions on uploading your manuscript, please read the submission instructions on the Journal of Cosmetic Dermatology online submission site: (http://mc.manuscriptcentral.com/JCD). Any major word processing software may be used, and both DOS-based and Macintosh operating systems are acceptable. Authors with no Internet connection should contact the Editorial Office. The author checklists should all be completed during the submission process.
Complete instructions for preparing and submitting manuscripts online are provided at the submission site. If you need assistance, please contact our support staff by phone at 1-888-503-1050 or via the red Get Help Now link in the upper right-hand corner of the login screen.
A structured abstract of not more than 250 words should accompany each manuscript. Abstracts for original contributions should be divided by individual headings into paragraphs entitled: Background, Objectives, Methods, Results, and Conclusions. Abbreviations or references to figures or tables should not be utilized in the abstract. We reserve the right to copy edit all accepted manuscripts. Proofs will be sent to the corresponding author for final approval. Authors will be billed for excessive changes on proofs (not due to printer error). They must be returned within 48 hours of receipt.
Please contact the Editorial Office with any questions:
Christine Lynch
jcdeditorialoffice@yahoo.com
Papers must be submitted exclusively to the Journal of Cosmetic Dermatology and are accepted on the understanding that they have not been and will not be published elsewhere. All authors must give signed consent to publication in a letter sent with the manuscript. Authorship implies a substantial contribution.
The corresponding author, who will be responsible for reading the proofs, should provide telephone and fax numbers and an e-mail address. To expedite the review process, please suggest three or four potential reviewers, providing their email addresses. It would also be helpful to have their addresses, telephone numbers and e-mail addresses.
The Editor retains the usual right to modify the style and length of a contribution (major changes being agreed with the corresponding author) and to decide the time of publication.
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:
Creative Commons Attribution License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see Wiley's Online Open website.
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at:
http://olabout.wiley.com/WileyCDA/Section/id-406241.html.
Ethics
Human studies should have been approved by an ethics committee but in questionable matters the Editor reserves the right to reject papers.
Sources of financial support must be acknowledged. Other kinds of association (such as consultancy, share ownership, or patent-licensing arrangements) should be disclosed to the Editor in a covering letter at the time of submission. Such information will be held in confidence.
SECTIONS OF THE JOURNAL TO WHICH SUBMISSIONS ARE ACCEPTED
Original Articles
Peer reviewed submissions of high quality that have not been published elsewhere. International submissions from all parts of the globe are encouraged as the Associate Editors are international in scope. Reviewers will be encouraged to submit commentaries to accompany the accepted article they evaluated. The title page should contain the author’s name(s), appointments and place of work at the relevant time. A full and a short running title should be given, together with no more than six keywords for indexing purposes.
The text should start with a structured Abstract, not exceeding 250 words, and organized into sections under the headings Background, Aims, Patients/Methods, Results, Conclusions. The paper should then proceed conventionally: Introduction, Materials and Methods, Results and Discussion. No more than 25 references should be cited.
Reports of clinical trials should adhere to the tenets of the CONSORT statement (JAMA 1996; 276: 637-639).
Editorial Echoes
An editorial on an area of cosmetic dermatology evaluating timely issues of a policy or trend nature.
Cosmetic Commentary
An article written by a dermatologist or industry researcher regarding a controversial or poorly understood issue, condition or treatment pertinent to cosmetic dermatology.
Review Articles
An article written by a dermatologist or industry researcher reviewing an important body of knowledge relevant to cosmetic dermatology, such as inflammation, a class of ingredients, a new testing methodology, a dermatologic technique, a product class, etc. These should follow the same format as original articles, but should be limited to a maximum of 2,500 words and 40 references.
Master Case Presentations
A photograph will be sent to a well-respected dermatologist who is expert in a certain field for analysis and development of a cosmetic dermatology treatment protocol. The treatment protocol will be presented in detail to help other dermatologists learn to develop their own treatment ideas. Surgical and medical and cosmetic issues will be discussed. Case reports including diagnosis and treatment of novel cosmetic dermatology issues will also be included in this section of the journal. These should be on topics of unusual interest. They should begin with a structured abstract of no more than 250 words, followed by the main text (no more than 800 words, excluding references). No more than 10 references should be cited.
Back to Basics
A concise discussion of a basic area of cosmetic dermatology to provide a review for dermatologists and a cosmetic dermatology knowledge base for resident dermatologists. Topics presented would be how does soap function, what constitutes a moisturizer, how does an antioxidant protect skin, etc.
Meeting Moments
A brief review of the important cosmetic dermatology presentations from major medical meetings around the world.
Journal Innoventions
A novel technique or active or industry development will be presented in an informal article. This is intended to allow cutting edge information that has not been written in a formal paper to be published.
Parting Thoughts
An inspirational thought regarding some area of cosmetic dermatology. For example, extrapolating on the future of an ingredient or technology.
Illustrations
Color illustrations are encouraged, and will not attract a cost to authors. There are three preferred formats for digital artwork submission: Encapsulated PostScript (EPS), Portable Document Format (PDF), and Tagged Image Format (TIFF). We suggest that line art be saved as EPS files. Alternately, these may be saved as PDF files at 600 dots per inch (dpi) or better at final size. Tone art, or photographic images, should be saved as TIFF files with a resolution of 300 dpi at final size. For combination figures, or artwork that contains both photographs and labeling, we recommend saving figures as EPS files, or as PDF files with a resolution of 600 dpi or better at final size. More detailed information on the submission of electronic artwork can be found at http://authorservices.wiley.com/bauthor/illustration.asp.
Four sets of original illustrations should only be mailed if it is not possible to submit them electronically. Each set should be placed in a separate envelope labeled with the senior author’s name and the manuscript title. All illustrations of graphs, artwork, and photographs should be numbered in consecutive Arabic numerals and submitted as high-contrast, glossy prints, 5 ×7 inches. Since all illustrations are reduced in size for publication, lettering should be sufficiently large to be legible upon reduction. Original artwork should not be submitted unless requested. X-ray photographs should be submitted as high-contrast, glossy prints, with the light and dark areas the same as the original x-ray. A gummed label should be affixed to the back of each illustration with the name of the senior author, manuscript title, figure number, and an arrow indicating the top of the figure. The legend(s) of all figures should be typed double-spaced on a separate sheet of paper. When appropriate, arrows should be placed on photographs and drawings to indicate the portion to which reference is made. In the legend for photomicrographs, the magnification and stain utilized should be included.
Slides are also acceptable, but should be packed in a padded envelope or disk mailer, as damage can occur in transit.
Diagrams should be on separate sheets; they should be drawn with black ink on white paper, or feint-ruled graph paper, and should be approximately twice the size of the final reproduction. Lines should be of sufficient thickness to stand reduction (no less than 4 mm high for a 50% reduction). A legend should be provided for each illustration, and in the case of photomicrographs, should state the original magnification.
Author Material Archive Policy
Please note that unless specifically requested, Blackwell Publishing will dispose of all hardcopy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the editorial office or production Editor as soon as possible if you have not already done so.
Units and Abbreviations
All measurements should be in SI units with the exception of haemoglobin (g/dL) and blood pressure (mmHg). Original observations recorded in other units should be stated, together with the appropriate conversion factors.
Standard abbreviations, without punctuation, are used. Units, Symbols and Abbreviations (1988) published by the Royal Society of Medicine, and SI: The International System of Units (1982), from HMSO provide useful guides.
Abbreviated words must be spelled out on first appearance in both summary and text. Abbreviations, used sparingly, should follow the first full spelling, in parentheses.
Drug Names
Generic names must be used. If an author so desires, brand names may be inserted in parentheses.
Statistics
Methods should be referenced. Two-tailed significance tests should be used unless explicitly stated. Controls should be described as completely as experimental subjects.
Measures of location should be accompanied by measures of variability (e.g. mean and confidence intervals) as well as conventional probability values. Clinical trial reports should include the power of the study design.
References
Use the Vancouver system. References should be numbered in the order in which they are first mentioned in the text, and should be identified in the text, tables and legends by arabic numbers in parentheses.
References must be verified by the authors against the original documents.
References to articles and papers should mention: (1) name(s) followed by the initials of the author(s), up to four authors: if more than four authors, include the first three authors followed by et al.; (2) title of paper; (3) title of the journal abbreviated in the standard manner; (4) year of publication; (5) volume; (6) first and final page numbers of the article.
Thus: Cunliffe WJ, Shuster S. The rate of sebum excretion in man. Br J Dermatol 1969; 81: 697-9.
References to books and monographs should include: (1) author(s) or editors(s); (2) chapter (if relevant) and book titles; (3) edition, volume, etc; (4) place; (5) publisher; (6) year; (7) page(s) referred to.
Thus: MacKie RM. Lymphomas and leukaemias. In: Textbook of Dermatology (Champion RH, Burton JL, Ebling FJG, eds), 5th edn., Vol. 3. Oxford: Blackwell Scientific Publications, 1992: 2107-34.
References to personal communications, unpublished data and manuscripts either ‘in preparation’ or ‘submitted for publication’ should be avoided. If they are essential, list in the text only and not in the listed references.
Page Proofs
Page proofs will be sent via e-mail as an Acrobat PDF file to the corresponding author. Acrobat reader is required to read these proofs and it can be downloaded free of charge from http://www.adobe.com/prodindex/acrobat/main.html This will enable the proof to be opened, read on screen and printed out for any corrections to be made. Further instructions will be sent to authors when they receive their proofs. Proof corrections should be returned to Wiley-Blackwell within three days. Major alterations to the text cannot be accepted.
PDF Offprints
Free access to the final PDF offprint of your article will be available via author services. Please sign up for author services if you would like to access your article PDF offprint upon publication of your paper, and enjoy the many other benefits the service offers. Visit http://authorservices.wiley.com/bauthor/ to sign up for author services.
Editorial Board
Editorial Board
Associate Editors
Murad Alam, MD, USA
Marc Avram, MD, USA
Anthony Benedetto, DO,USA
Patricia Farris, MD, USA
Michael H. Gold, MD, USA
Mitchel Goldman, USA
Greg Goodman, AUSTRALIA
Gerald Pierard, MD, PhD, BELGIUM
Rao Jaggi, MD, CANADA
Lawrence Rhines, PhD, USA
Neil Sadick, MD, USA
Marcia Ramos-e-Silva, MD, PhD, BRAZIL
Tsai Ren-Yeu, MD, TAIWAN
Advisory Committee
Pierre Andre,MD, FRANCE
Robert Baran, MD, FRANCE
Frederic Bonte, PhD, FRANCE
Alex Camps Fresneda, MD, SPAIN
Joel Cohen, MD, USA
Ncoza Dlova, SOUTH AFRICA
Lisa Donofrio, MD, USA
Richard Fitzpatrick, MD, USA
Alina Fratila, MD, GERMANY
Bryan Fuller, PhD, USA
Barbara Green, USA
Eckart Haneke, MD, NORWAY
Chris Harmon, MD, USA
Jana Hercogova, MD, CZECH REP
Philippe Humbert, MD, FRANCE
Jurgen Lademann, MD, GERMANY
Jan Lephart, USA
Jean-Luc Levy, MD, FRANCE
Torello Lotti, MD, ITALY
Ken Marenus, PhD, USA
Gopi Menon, PhD, USA
Larry Millikan, MD, USA
Rhoda Narins, MD, USA
Keyvan Nouri, MD, USA
Christian Oresajo, USA
Lawrence Parish, MD, USA
Thomas Polefka, PhD, USA
Andre Rougier, PhD, FRANCE
Jean-Hilaire Saurat, SWITZERLAND
Tony Simion, PhD, USA
Shyam Verma, MBBS, DV&D, INDIA
Daniel Wallach, MD, FRANCE
Teresa Weber, PhD, USA
Ronni Weinkauf, USA
Robert Weiss, MD, USA
Tina West, MD, USA
Uwe Wollina, MD, GERMANY
Wolf-Ingo Worret, MD, GERMANY
Hana Zelenkova, MD, SLOVAKIA
| 
